Dianthus Therapeutics (DNTH) Other Non-Current Assets: 2017-2025
Historic Other Non-Current Assets for Dianthus Therapeutics (DNTH) over the last 7 years, with Sep 2025 value amounting to $9.3 million.
- Dianthus Therapeutics' Other Non-Current Assets rose 3941.48% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 3941.48%. This contributed to the annual value of $9.6 million for FY2024, which is 734.40% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Other Non-Current Assets stood at $9.3 million, which was up 0.81% from $9.2 million recorded in Q2 2025.
- Dianthus Therapeutics' Other Non-Current Assets' 5-year high stood at $9.6 million during Q4 2024, with a 5-year trough of $60,000 in Q3 2022.
- For the 3-year period, Dianthus Therapeutics' Other Non-Current Assets averaged around $3.4 million, with its median value being $229,000 (2024).
- Its Other Non-Current Assets has fluctuated over the past 5 years, first plummeted by 96.63% in 2023, then spiked by 13,810.61% in 2025.
- Quarterly analysis of 4 years shows Dianthus Therapeutics' Other Non-Current Assets stood at $121,000 in 2022, then skyrocketed by 853.72% to $1.2 million in 2023, then soared by 734.40% to $9.6 million in 2024, then spiked by 3,941.48% to $9.3 million in 2025.
- Its Other Non-Current Assets stands at $9.3 million for Q3 2025, versus $9.2 million for Q2 2025 and $7.6 million for Q1 2025.